PFCS
Pale Fire Capital SE Portfolio holdings
AUM
$958M
1-Year Return
80.1%
This Quarter Return
+23.55%
1 Year Return
+80.1%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$830M
AUM Growth
+$403M
(+95%)
Cap. Flow
+$318M
Cap. Flow
% of AUM
38.26%
Top 10 Holdings %
Top 10 Hldgs %
90.97%
Holding
70
New
19
Increased
27
Reduced
11
Closed
8
Top Buys
| 1 |
B
Barrick Mining Corporation
B
|
+$146M |
| 2 |
Hecla Mining
HL
|
+$41.4M |
| 3 |
B2Gold
BTG
|
+$35.4M |
| 4 |
Coeur Mining
CDE
|
+$29.1M |
| 5 |
NGD
New Gold Inc
NGD
|
+$23.9M |
Top Sells
| 1 |
International Seaways
INSW
|
+$7.99M |
| 2 |
TEN
Tsakos Energy Navigation Ltd.
TEN
|
+$2.15M |
| 3 |
Navios Maritime Partners
NMM
|
+$1.97M |
| 4 |
uniQure
QURE
|
+$1.25M |
| 5 |
Teladoc Health
TDOC
|
+$1.01M |
Sector Composition
| 1 | Materials | 57.66% |
| 2 | Communication Services | 25.17% |
| 3 | Consumer Staples | 10.92% |
| 4 | Healthcare | 3.48% |
| 5 | Energy | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Talos Energy
TALO
$1.68B
| $1M | 0.12% |
+103,236
| New | +$1M |
|
27
Caribou Biosciences
CRBU
$168M
| $718K | 0.09% |
786,722
+52,518
| +7% | +$48K |
|
|
CYBN
28
Cybin
CYBN
$144M
| $715K | 0.09% |
112,805
+51,893
| +85% | +$329K |
|
|
QIPT
29
Quipt Home Medical
QIPT
$117M
| $574K | 0.07% |
+246,496
| New | +$574K |
|
30
X4 Pharmaceuticals
XFOR
$73.2M
| $481K | 0.06% |
67,845
+21,113
| +45% | +$150K |
|
|
INZY
31
DELISTED
Inozyme Pharma
INZY
| $401K | 0.05% |
440,807
+222,270
| +102% | +$202K |
|
|
MITT
32
AG Mortgage Investment Trust
MITT
$244M
| $374K | 0.04% |
51,202
| – | – |
|
33
Triple Flag Precious Metals
TFPM
$5.92B
| $278K | 0.03% |
+14,520
| New | +$278K |
|
34
Day One Biopharmaceuticals
DAWN
$729M
| $251K | 0.03% |
31,693
+15,687
| +98% | +$124K |
|
35
UroGen Pharma
URGN
$869M
| $231K | 0.03% |
20,893
+8,393
| +67% | +$92.8K |
|
36
Harrow
HROW
$1.46B
| $216K | 0.03% |
+8,133
| New | +$216K |
|
37
Regenxbio
RGNX
$465M
| $185K | 0.02% |
25,846
+14,125
| +121% | +$101K |
|
38
89bio
ETNB
$1.2B
| $180K | 0.02% |
24,778
-5,661
| -19% | -$41.2K |
|
39
Celcuity
CELC
$2.33B
| $178K | 0.02% |
17,640
+182
| +1% | +$1.84K |
|
|
ADAM
40
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $177K | 0.02% |
27,301
| – | – |
|
41
Journey Medical
DERM
$187M
| $161K | 0.02% |
+27,274
| New | +$161K |
|
|
VERV
42
DELISTED
Verve Therapeutics
VERV
| $158K | 0.02% |
34,500
-10,300
| -23% | -$47.1K |
|
43
Arrowhead Research
ARWR
$4.11B
| $156K | 0.02% |
+12,221
| New | +$156K |
|
44
Immatics
IMTX
$707M
| $155K | 0.02% |
34,270
+2,808
| +9% | +$12.7K |
|
45
Iovance Biotherapeutics
IOVA
$821M
| $143K | 0.02% |
42,897
+4,022
| +10% | +$13.4K |
|
46
Rezolute
RZLT
$669M
| $137K | 0.02% |
47,122
+3,935
| +9% | +$11.4K |
|
|
ODV
47
Osisko Development Corp
ODV
$733M
| $97.2K | 0.01% |
65,265
+36,774
| +129% | +$54.8K |
|
48
Cleveland-Cliffs
CLF
$5.78B
| $82.2K | 0.01% |
+10,000
| New | +$82.2K |
|
|
NEWP
49
New Pacific Metals
NEWP
$374M
| $81.1K | 0.01% |
73,430
+31,300
| +74% | +$34.6K |
|
50
Larimar Therapeutics
LRMR
$336M
| $80.7K | 0.01% |
37,518
+5,209
| +16% | +$11.2K |
|